day 1 agenda
| Tentative Program | |
| Day -1: July(07, 2025) | |
| Meeting Hall | |
| 08:00-09:00 | Registrations Open |
| 09:00-09:15 | Opening Ceremony |
| Keynote Talks | |
| 09:15-09:45 | Title: TFEB is a master regulator of tumor-associated macrophages in breast cancer |
| Daping Fan, University Of South Carolina, USA | |
| 09:45-10:15 | Title: Targeted Nanotherapy using CRISPR/Cas9 for Genetically Knocking down Highly Specific Genes for Basal-like Breast Cancer |
| Dipanjan Pan, The Pennsylvania State University, USA | |
| 10:15-10:45 | Title: Distinct Tumor Immune Responses to Nanosecond Pulsed Electric Fields (nsPEFs) Determine Immunity |
| Stephen Jack Beebe, Old Dominion University, USA | |
| 10:45-11:00 | Group Photo & Refreshment Break |
| SCIENTIFIC SESSION-I | |
| 11:00-11:20 | Title: Breast Cancer Eradication by Steroid Receptor Coactivator-3 Deleted Regulaotry T Cells |
| Sang Jun Han, Baylor College of Medicine, USA | |
| 11:20-11:40 | Title: Technological Innovations Enable the 24-hour Discharge of Patients Who Undergo Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Breast Reconstruction: Safety and Aesthetic Outcomes from A Single-Centre, Prospective Cohort Study |
| Zhenggui Du, West China Hospital of Sichuan University, Sofia, China | |
| 11:40-12:00 | SPEAKER SLOT AVAILABLE |
| 12:00-12:20 | Title: Comparative Evaluation of Biological Activity of Anti-Breast Cancer Monoclonal Antibodies |
| Harish Chander, National Institute of Biologicals, USA | |
| 12:20-12:40 | Title: Targeting Integrated Stress Response (ISR) Pathway inactivation to restore tumor immunity in metastatic triple negative breast cancer |
| Hariprasad Vankayalapati, Biolexis Therapeutics, USA | |
| 12:40-13:00 | Title: The Revolution in Understanding Breast Cancer Recurrences |
| Howard Petty, University of Michigan, USA | |
| Networking & Panel Discussion | |
| 13:00-14:00 Lunch Break @ Restaurant | |
| SCIENTIFIC SESSION-II | |
| 14:00-14:20 | Title: Breast Cancer Screening in the Elderly United States Population: Challenges and Future Considerations |
| Jessica Burgers, Holy Cross Health, USA | |
| 14:20-14:40 | Title: A Precision engineered approach based on modular assembly for in vitro expansion of low-abundance antigen-specific T cells |
| Zhangyong Hong, Nankai University, China | |
| 14:40-15:00 | Title: SDG like Bioactive Constituent of C. gouriana Exhibits Anticancer Potential in Breast Cancer Cells |
| Reena Jassal, Punjabi University, India | |
| 15:00-15:20 | SPEAKER SLOT AVAILABLE |
| 15:20-15:40 | Title: Postoperative outcomes of minimally-invasive nipple-sparing mastectomy with immediate breast reconstruction versus conventional approach in women with early breast cancer – a single centre experience |
| Marc Ong Weijie, Khoo Teck Puat Hospital, Singapore | |
| 15:40-16:00 | SPEAKER SLOT AVAILABLE |
| 16:00-16:20 | Title: Comparing Narrow and Wide Angle Digital Breast Tomosynthesis |
| Tanya W. Moseley, The University of Texas MD Anderson Cancer Center, USA | |
| 16:20-16:40 | Title: "Acetalax (Oxyphenisatin Acetate, NSC 59687) and Bisacodyl Cause a Nonapoptotic Cell Death, Oncosis, in Triple-Negative Breast Cancer Cell Lines with the causal involvement of the Ion Exchange Membrane Protein TRPM4.” |
| William C. Reinhold, National Institutes of Health, USA | |
| 16:40-17:00 | Title: FGF/FGFR-SIGNALLING IN RESPONSE TO THERAPY IN TRIPLE-POSITIVE BREAST CANCER |
| Hanna Romanska-Knight, Medical University of Lodz, Poland | |
| 17:00-17:10 Refreshment Break | |
| 17:10-17:30 | Title: The effect of deuterium depletion on the survival outcomes of cancer patients and recurrence of the disease |
| Gabor Somlyai, HYD LLC for Cancer Research and Drug Development, Hungary | |
| 17:30-17:50 | Title: Hypoxia modulates the XBP1s/HDAC2/EZH2-ΔNp63α axis to promote breast cancer metastasis independent of HIF1α |
| Zhixiong Jim Xiao, Sichuan University, China | |
| 17:50-18:10 | Title: Clinico-genomic findings, molecular docking, and mutational spectrum in an understudied population with breast cancer patients from KP, Pakistan |
| Amna Mehmood, Martin Luther University Halle-Wittenberg, Germnay | |
| Networking & Panel Discussion | |
| Day-1 Concludes | |
| If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org | |
day 2 agenda
| Day -2: July(08, 2025) | |
| Keynote Talks | |
| 09:15-09:45 | Title: Radioguided occult lesion localisation for non-palpable breast lesions in combination with radioisotope sentinel lymph node localisation (SNOLL) – 10 year experience of a single centre |
| Maged Hussien, Norfolk and Norwich University hospital, United Kingdom | |
| 09:45-10:15 | Title: Poor oral health and cancer – why does it matter? |
| Jukka H. Meurman, University of Helsinki and Helsinki University, Finland | |
| 10:15-10:45 | TBA |
| 10:45-11:00 Refreshment Break | |
| SCIENTIFIC SESSION-III | |
| 11:00-11:20 | Title: Identification of Novel Markers for TTK Inhibitor and Taxane Sensitivity in Triple-Negative Breast Cancer |
| Lei Duan, Rush University Medical Center, USA | |
| 11:20-11:40 | SPEAKER SLOT AVAILABLE |
| 11:40-12:00 | Title: Growth inhibitory effect of Leptospermum scoparium (manuka) chloroform extract on breast and liver cancer cell lines |
| Mohammed Musa Yahya Alzahrani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia | |
| 12:00-12:20 | SPEAKER SLOT AVAILABLE |
| 12:20-12:40 | Title: Potential of epithelial membrane protein 3 as a novel therapeutic target for human breast cancer |
| Nan-Haw Chow, China Medical University Hospital, Taiwan | |
| 12:40-13:00 | SPEAKER SLOT AVAILABLE |
| Networking & Panel Discussion | |
| 13:00-14:00 Lunch Break @ Restaurant | |
| SCIENTIFIC SESSION-IV | |
| 14:00-14:20 | SPEAKER SLOT AVAILABLE |
| 14:20-14:40 | Title: A new modality for cancer tracking - Raman imaging, nanoIR imaging, fluorescence and AFM studies combined with AI analysis |
| Halina Abramczyk, Lodz University of Technology, Poland | |
| 14:40-15:00 | SPEAKER SLOT AVAILABLE |
| 15:00-15:20 | Title: Wild-Type p53 Restrains CIP4 to Suppress Breast Cancer Metastatic Risk |
| Sohidul Islam, Academy of Scientific and Innovative Research, India | |
| 15:20-15:40 | Title: Discovery and development of mitochondrial fission-dependent non-apoptotic cell death inducers for TNBC therapy |
| Amit K. Tiwari, University of Arkansas for Medical Sciences, AR, USA | |
| 15:40-16:00 | Title: TBA |
| Izabela M?ynarczuk-Bia?y, Warsaw Medical University, Poland | |
| 16:00-16:20 | Title: Detection of Circulating Tumor Cells by Cell Block Technique in Malignant Tumors |
| Jahnvi Vijay, Rajiv Gandhi University of Health Sciences, India | |
| 16:20-16:30 Refreshment Break | |
| 16:30-16:50 | SPEAKER SLOT AVAILABLE |
| 16:50-17:10 | Title: TBA |
| Vagif Kalender (Galandarov), Azerbaijan Medical University, Azerbaijan | |
| 17:10-17:30 | Title: Synergistic Action of Benzyl Isothiocyanate and Sorafenib in a Nanoparticle Delivery System for Enhanced Triple-Negative Breast Cancer Treatment |
| Qi Wang, Norwich Medical School University, UK | |
| 17:30-17:50 | SPEAKER SLOT AVAILABLE |
| 17:50-18:10 | SPEAKER SLOT AVAILABLE |
| Networking & Panel Discussion | |
| Closing Ceremony | |
| If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org | |
Virtual agenda
| Day -2: July 08th, 2025 Time Zone: Central European Time (CET) |
|
| Virtual Presentations | |
| Title: One stage single port endoscopic breast cancer reconstruction with Bra-flap technique and direct to implant : a four-year case series report of SmoothSilk implant | |
| Tsung Chun Huang, China Medical University Hospital, Taiwan | |
| Title: Microwave ablation treatment of non-lactating mastitis | |
| Aili Saiding, Guangyuan Central Hospital, China | |
| Title: CanAssist Breast: First Proteomics and Artificial Intelligence Based Cost-effective Prognostic Test: Real world data | |
| Manjiri Bakre, OncoStem Diagnostics Pvt Ltd, India | |
| Title: Breast cancer survivors, psychological distress and quality of life: a multifaceted model of healthcare | |
| Syeda Zakia Hossain, The University of Sydney, Australia | |
| Title: The impact of bitter taste genes TAS2R38 and CA6 and breast cancer risk | |
| Dorota Lukasiewicz-Smietanska, National Research Institute, Poland | |
| SPEAKER SLOT AVAILABLE | |
| Title: Novel therapeutic approaches in development for hormone receptor-positive metastatic breast cancer | |
| Richard Baird , china Medical University Hospital, UK | |
| Title: Introducing Cosmosort: The Next Generation Spatial Cell Sorter | |
| Haewook Jang, Meteorbiotech, South korea | |
| Title: TBA | |
| Bharati Pandya, AIIMS Bhopal, India | |
| SPEAKER SLOT AVAILABLE | |
| Title: Factors Influencing Adherence to Endocrine Therapy After Breast Cancer Surgery | |
| Aina Johnsson, Karolinska Institutet, Sweden | |
| Title: Investigating the anti-cancer and cardioprotective role of a novel metabolite | |
| Tapasree Roy Sarkar, Texas A & M University, USA | |
| SPEAKER SLOT AVAILABLE | |
| SPEAKER SLOT AVAILABLE | |
| Title: Minimally Invasive Breast Cancer: How to Find Early Breast Cancers | |
| Harnoor Singh, University of Texas at Houston, USA | |
| SPEAKER SLOT AVAILABLE | |
| SPEAKER SLOT AVAILABLE | |
| Title: The identification and potential mechanism of SET7/9 as a tumor biomarker in breast cancer | |
| Wenzhe Si, Peking University Third Hospital, China | |
| Title: Multi-modal microscopy for treatment of breast cancer cells with zirconium-based nano-particles | |
| Herbert Schneckenburger, Aalen University, Germany | |
| SPEAKER SLOT AVAILABLE | |
| Title: Curcumin and doxorubicin delivered by biocompatible clay-based nanomaterials to overcome multidrug resistance in breast cancer | |
| Paola Poma, University of Palermo, Italy | |
| Title: TBA | |
| Katia Cortese, University of Genoa, Italy | |
| SPEAKER SLOT AVAILABLE | |
| Closing Ceremony | |
| If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org | |